{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:11:26Z","timestamp":1749096686087,"version":"3.41.0"},"reference-count":104,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":4269,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS spectr."],"published-print":{"date-parts":[[2003,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sexual dysfunction related to antidepressants, particularly serotonin reuptake inhibitors is a major cause of premature treatment discontinuation. This places patients at increased risk for recurrence, relapse, chronicity, and mortality (eg, suicide). The clinical assessment requires a comprehensive evaluation of sexual function, including libido, arousal, orgasm, and resolution prior to affective disorder, disturbances associated with the emergence of depression, and changes or dysfunctions associated with antidepressant treatment. Other factors to be included for evaluating sexual dysfunction include inquiry for concurrent medical conditions, somatic treatments, lifestyle risk factors, and response to antidepressants. Current treatment approaches to antidepressant-associated sexual dysfunction have relied on open-label reports, literature reviews, and clinical wisdom. Without double-blind, placebo-controlled studies to support them, too much non-evidence-based treatment may be offered to patients. Advances into nonadrenergic-noncholinergic novel signal transduction, specifically phosphodiesterase type-5 inhibitors, offer new opportunities for developing evidence-based treatments for this side effect and improving depression disease management outcomes.<\/jats:p>","DOI":"10.1017\/s1092852900024433","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T03:23:56Z","timestamp":1470108236000},"page":"194-202","source":"Crossref","is-referenced-by-count":11,"title":["Selective Phosphodiesterase Type-5 Inhibitor Treatment of Serotonergic Reuptake Inhibitor Antidepressant-Associated Sexual Dysfunction: A Review of Diagnosis, Treatment, and Relevance"],"prefix":"10.1017","volume":"8","author":[{"given":"H. George","family":"Nurnberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula L.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S1092852900024433_ref070","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)63299-3"},{"key":"S1092852900024433_ref036","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.144.6.805","article-title":"Spontaneous remission of MAOI-induced anorgasmia","volume":"144","author":"Nurnberg","year":"1987","journal-title":"Am J Psychiatry"},{"key":"S1092852900024433_ref042","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1106d"},{"volume-title":"Mirtazapine substitution in SSRI-induced sexual dysfunction","year":"1997","author":"Gelenberg","key":"S1092852900024433_ref031"},{"key":"S1092852900024433_ref084","doi-asserted-by":"publisher","DOI":"10.1159\/000012299"},{"key":"S1092852900024433_ref026","first-page":"10","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction","volume":"62","author":"Montejo","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"S1092852900024433_ref078","first-page":"339","article-title":"Effects of phosphodiesterase-5 inhibition on myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers","volume":"35","author":"Pelliccia","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"S1092852900024433_ref033","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200103000-00003"},{"key":"S1092852900024433_ref025","doi-asserted-by":"publisher","DOI":"10.1080\/00926239708403923"},{"volume-title":"Physicians' Desk Reference","year":"2002","key":"S1092852900024433_ref024"},{"key":"S1092852900024433_ref044","first-page":"124","article-title":"Treatment of sexual side effects with dopaminergic agents [letter]","volume":"56","author":"Gitlin","year":"1995","journal-title":"J Clin Psychiatry"},{"volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994","key":"S1092852900024433_ref011"},{"key":"S1092852900024433_ref030","first-page":"251","article-title":"Neuroendocrine effects of a 20 mg citalopram infusion in healthy males","volume":"13","author":"Seifritz","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"S1092852900024433_ref023","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199807000-00011"},{"key":"S1092852900024433_ref040","doi-asserted-by":"publisher","DOI":"10.1080\/00926239608404410"},{"key":"S1092852900024433_ref021","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00050-6"},{"key":"S1092852900024433_ref019","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790340082012"},{"key":"S1092852900024433_ref068","first-page":"663","article-title":"Sildenafil, a novel effective oral therapy for male erectile dysfunction","volume":"79","author":"Boolell","year":"1997","journal-title":"Br J Urol"},{"key":"S1092852900024433_ref018","first-page":"54","volume-title":"J Urol","author":"Feldman","year":"1994"},{"key":"S1092852900024433_ref067","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90361-1"},{"key":"S1092852900024433_ref017","doi-asserted-by":"publisher","DOI":"10.1007\/BF01541404"},{"key":"S1092852900024433_ref022","first-page":"755","article-title":"Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory","volume":"33","author":"Zajecka","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"S1092852900024433_ref016","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/009262300278542","article-title":"Satisfaction in the sex life of a general population sample","volume":"26","author":"Dunn","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"S1092852900024433_ref014","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.537"},{"volume-title":"Disorders of Sexual Desire","year":"1979","author":"Kaplan","key":"S1092852900024433_ref013"},{"key":"S1092852900024433_ref009","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200013050-00003"},{"key":"S1092852900024433_ref043","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0611"},{"volume-title":"Beyond Diagnosis: A Landmark Survey of Depression and Treatment","year":"2000","key":"S1092852900024433_ref007"},{"key":"S1092852900024433_ref104","first-page":"535","article-title":"Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors","volume":"44","author":"Shen","year":"1999","journal-title":"J Reprod Med"},{"volume-title":"Depression in Primary Care; Vol 2-Treatment of Major Depression","year":"1993","key":"S1092852900024433_ref005"},{"key":"S1092852900024433_ref002","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199201000-00007"},{"key":"S1092852900024433_ref048","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.2.239"},{"key":"S1092852900024433_ref001","first-page":"1","volume":"20","year":"1999","journal-title":"Adv Data"},{"key":"S1092852900024433_ref035","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200104000-00006"},{"key":"S1092852900024433_ref032","first-page":"35","article-title":"Strategies for the treatment of antidepressant-related sexual dysfunction","volume":"62","author":"Zajecka","year":"2001","journal-title":"J Clin Psychiatry"},{"volume-title":"Sildenafil citrate for serotonergic reuptake inhibitor-antidepressant associated female sexual dysfunction","year":"2002","author":"Nurnberg","key":"S1092852900024433_ref100"},{"key":"S1092852900024433_ref074","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018120-00022"},{"key":"S1092852900024433_ref038","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/ajp.151.3.453a","article-title":"Yohimbine and pentoxifiline in the treatment of erectile dysfunction [letter]","volume":"151","author":"Nessel","year":"1994","journal-title":"Am J Psychiatry"},{"key":"S1092852900024433_ref010","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199606002-00001"},{"key":"S1092852900024433_ref080","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1926"},{"key":"S1092852900024433_ref034","first-page":"S49","article-title":"Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors","volume":"13","author":"Nurnberg","year":"2001","journal-title":"Intl J Impot Res"},{"key":"S1092852900024433_ref029","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0414"},{"key":"S1092852900024433_ref075","first-page":"497","article-title":"Viagra (sildenafil citrate) for the treatment of erectile dysfunction in men with multiple sclerosis","volume":"46","author":"Fowler","year":"1999","journal-title":"Ann Neurol"},{"key":"S1092852900024433_ref027","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0307"},{"key":"S1092852900024433_ref046","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.7.652"},{"key":"S1092852900024433_ref008","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199902000-00013"},{"key":"S1092852900024433_ref039","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199502000-00014"},{"key":"S1092852900024433_ref073","first-page":"21","article-title":"Sildenafil citrate (Viagra) efficacy in the treatment of erectile dysfunction in patients with common concomitant conditions. Sildenafil Study Group","volume":"102","author":"Price","year":"1999","journal-title":"Int J Clin Pract Suppl"},{"key":"S1092852900024433_ref094","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19990101-11"},{"volume-title":"Substitution of SSRI with bupropion SR following SSRI-induced sexual dysfunction. Poster presented at: the Annual Meeting of the American Psychiatric Association","year":"1999","author":"Clayton","key":"S1092852900024433_ref059"},{"key":"S1092852900024433_ref004","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7314.647"},{"key":"S1092852900024433_ref095","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00633-5"},{"key":"S1092852900024433_ref089","doi-asserted-by":"publisher","DOI":"10.1080\/00926239808403967"},{"key":"S1092852900024433_ref047","doi-asserted-by":"publisher","DOI":"10.1080\/00926239808404927"},{"key":"S1092852900024433_ref049","first-page":"53","article-title":"Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction","volume":"57","author":"Feiger","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"S1092852900024433_ref045","doi-asserted-by":"publisher","DOI":"10.1080\/00926239508414646"},{"key":"S1092852900024433_ref028","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0107"},{"key":"S1092852900024433_ref003","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0902"},{"key":"S1092852900024433_ref091","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9206"},{"volume-title":"Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, CBASP, and their combination","year":"2000","author":"Zajecka","key":"S1092852900024433_ref051"},{"key":"S1092852900024433_ref052","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"key":"S1092852900024433_ref053","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1204"},{"key":"S1092852900024433_ref056","first-page":"7","article-title":"Cost effectiveness of selective serotonin reuptake inhibitor antidepressants: a dose stratification approach for agent cost comparisons","volume":"13","author":"Nurnberg","year":"2001","journal-title":"Drug Benefit Trends"},{"key":"S1092852900024433_ref058","doi-asserted-by":"publisher","DOI":"10.3109\/10401239409148833"},{"key":"S1092852900024433_ref057","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0304"},{"volume-title":"A double-blind, placebo-controlled trial of bupropion SR for SSRI-induced sexual dysfunction","year":"1999","author":"Masand","key":"S1092852900024433_ref060"},{"volume-title":"Bupropion SR as an antidote to SSRI-induced sexual dysfunction","year":"2002","author":"Clayton","key":"S1092852900024433_ref061"},{"volume-title":"Effects of double-blind treatment with nefazodone or sertraline on re-emergence of sexual dysfunction in depressed patients","year":"1996","author":"Ferguson","key":"S1092852900024433_ref050"},{"key":"S1092852900024433_ref062","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0302"},{"key":"S1092852900024433_ref063","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1999)9:4<175::AID-DA5>3.0.CO;2-0"},{"key":"S1092852900024433_ref064","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198606000-00004"},{"key":"S1092852900024433_ref065","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1176\/ajp.152.10.1514","article-title":"Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday","volume":"152","author":"Rothschild","year":"1995","journal-title":"Am J Psychiatry"},{"key":"S1092852900024433_ref054","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)88317-4"},{"key":"S1092852900024433_ref066","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00126-7"},{"volume-title":"Human Sexual Response","year":"1966","author":"Masters","key":"S1092852900024433_ref012"},{"key":"S1092852900024433_ref069","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1995.75.1.191"},{"key":"S1092852900024433_ref096","doi-asserted-by":"crossref","DOI":"10.1016\/S0020-7292(00)82403-0","volume-title":"Efficacy and safety of Viagra\u00ae in estrogenized women with sexual dysfunction associated with female sexual arousal disorder (FSAD)","author":"Basson","year":"2000"},{"key":"S1092852900024433_ref071","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805143382001"},{"key":"S1092852900024433_ref006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"key":"S1092852900024433_ref072","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P"},{"key":"S1092852900024433_ref076","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6.1629"},{"key":"S1092852900024433_ref077","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00659-2"},{"key":"S1092852900024433_ref037","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00004714-198610000-00027","article-title":"Cyproheptadine for imipramine-induced anorgasmia","volume":"6","author":"Steele","year":"1986","journal-title":"J Clin Psychopharmacol"},{"key":"S1092852900024433_ref079","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.10.1623"},{"volume-title":"Sildenafil citrate effectively treats erectile dysfunction in men who have been successfully treated for depression","year":"2001","author":"Tignol","key":"S1092852900024433_ref081"},{"volume-title":"Sildenafil treatment of serotonin-reuptake inhibitor (SRI)-induced sexual dysfunction","year":"2001","author":"Ginsberg","key":"S1092852900024433_ref082"},{"key":"S1092852900024433_ref083","first-page":"16","article-title":"Sildenafil treatment of SSRI antidepressant-induced sexual dysfunction","volume":"1","author":"Nurnberg","year":"2000","journal-title":"The Pfizer Journal of Psychiatry"},{"key":"S1092852900024433_ref085","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1999)9:4<180::AID-DA6>3.0.CO;2-#"},{"key":"S1092852900024433_ref086","doi-asserted-by":"publisher","DOI":"10.1080\/00926239908403986"},{"key":"S1092852900024433_ref087","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.1.157"},{"key":"S1092852900024433_ref090","first-page":"42","article-title":"Patients are talking about Viagra","volume":"2","author":"Singer","year":"1998","journal-title":"Strategic Medicine"},{"key":"S1092852900024433_ref092","doi-asserted-by":"publisher","DOI":"10.1176\/ps.50.8.1076"},{"key":"S1092852900024433_ref093","doi-asserted-by":"crossref","DOI":"10.1097\/00005392-199904010-00843","volume-title":"Double-blind placebo controlled study with crossover to assess effect of sildenafil on physiological parameters of the female sexual response","author":"Berman","year":"1999"},{"key":"S1092852900024433_ref097","first-page":"812","article-title":"Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury","volume":"55","author":"Sipski","year":"2000","journal-title":"Elsevier Science Inc"},{"key":"S1092852900024433_ref020","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"S1092852900024433_ref098","first-page":"623","article-title":"Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study","volume":"108","author":"Caruso","year":"2001","journal-title":"Br J Obstetrics Gynaecology"},{"key":"S1092852900024433_ref099","doi-asserted-by":"publisher","DOI":"10.1176\/ps.50.8.1076"},{"key":"S1092852900024433_ref101","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1176\/ajp.156.5.800","article-title":"Sildenafil treatment of paroxetine-induced anorgasmia in a woman [letter]","volume":"156","author":"Mottard","year":"1999","journal-title":"Am J Psychiatry"},{"key":"S1092852900024433_ref102","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.1.157"},{"volume-title":"An open-label trial of silednafil to reverse antidepressant-induced sexual dysfunction in women","year":"2000","author":"Bayer","key":"S1092852900024433_ref103"},{"key":"S1092852900024433_ref015","doi-asserted-by":"publisher","DOI":"10.1136\/jech.53.3.144"},{"key":"S1092852900024433_ref041","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1176\/ajp.144.9.1243b","article-title":"Reversal by bethanechol of imipramine-induced ejaculatory dysfunction","volume":"144","author":"Segraves","year":"1987","journal-title":"Am J Psychiatry"},{"volume-title":"The management of SSRI-induced side effects: a survey of psychiatrists","year":"2000","author":"Dording","key":"S1092852900024433_ref055"},{"key":"S1092852900024433_ref088","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.1.156a"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852900024433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:56:22Z","timestamp":1749034582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852900024433\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S1092852900024433"],"URL":"https:\/\/doi.org\/10.1017\/s1092852900024433","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"type":"print","value":"1092-8529"},{"type":"electronic","value":"2165-6509"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}